Reuters US Business

By Kanishka Singh WASHINGTON (Reuters) -The U.S. House of Representatives Select Committee on China said on Thursday it sent subpoenas addressed to JPMorgan Chase CEO Jamie Dimon and Bank of America CEO Brian Moynihan over their banks’ roles in underwriting the initial public offering of Chinese battery manufacturer CATL. The U.S. government has alleged that …

US House panel subpoenas JPMorgan, Bank of America CEOs over IPO of China’s CATL Read More »

By David Shepardson WASHINGTON (Reuters) -The National Highway Traffic Safety Administration said on Friday it has closed a 14-month investigation into a series of minor collisions and unexpected behavior from Alphabet’s Waymo self-driving vehicles without taking further action. The U.S. auto safety regulator in May 2024 opened an investigation after 22 reports about Waymo robotaxis …

US closes probe into Waymo self-driving collisions, unexpected behavior Read More »

By Siddhi Mahatole and Christy Santhosh (Reuters) -HCA Healthcare lifted its 2025 profit forecast but said it cannot determine how looming changes to insurance plans under Medicaid and Obamacare will impact 2026 earnings, sending the hospital operator’s shares down 2% on Friday. Some COVID-era subsidies under Obamacare are set to lapse in 2026. That would …

HCA lifts 2025 profit forecast, flags insurance policy uncertainty Read More »

By Arriana McLymore and Nicholas P. Brown NEW YORK (Reuters) -This holiday season, U.S. parents may have to make an extra pit stop – not for toys, but for the batteries that power them, as manufacturers pare down on frills and packaging to cut costs amid rising tariffs.  Toy makers that serve retail giants like Walmart, …

Toy makers nix batteries, other materials to save costs during tariff war Read More »

By Andrew Silver HANGZHOU (Reuters) -China’s Sciwind Biosciences is in talks with a U.S. company interested in licensing its experimental weight-loss drug for American patients, the drugmaker’s chief executive told Reuters. Overweight patients treated with Sciwind’s ecnoglutide drug lost an average of 10% to 15% of their body weight, roughly in line with results from …

Exclusive-China’s Sciwind is in talks to license weight-loss drug in US, CEO says Read More »

By Lucia Mutikani WASHINGTON (Reuters) -New orders for key U.S.-manufactured capital goods unexpectedly fell in June while shipments of those products increased moderately, suggesting that business spending on equipment slowed considerably in the second quarter. Front-loading of activity ahead of President Donald Trump’s aggressive and broad tariffs on imports resulted in business spending on equipment …

US business equipment spending appears to have slowed sharply in second quarter Read More »

(Reuters) -SpaceX’s Starlink satellite network was back up and running on Friday as engineers hunted for the root cause of one of its biggest international outages the night before, a rare disruption for the powerful internet system set off by an internal software failure. Users in the U.S. and Europe began experiencing the outage at …

SpaceX probes for cause of Starlink’s global satellite network outage Read More »